WAM
HURA

Warberg Asset Management’s TuHURA Biosciences HURA Stock Holding History

Warberg Asset Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,000
Closed -$44.8K – 228
2025
Q2 		$44.8K Buy
+20,000
New +$67.6K 0.01% 136

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Warberg Asset Management's HURA Position: Q3 2025 in Review

Warberg Asset Management sold out of TuHURA Biosciences (HURA) in Q3 2025, closing a stake of 20,000 shares — an estimated $44.8K sold.

Warberg Asset Management first reported a position in HURA in Q2 2025 and held it in 1 quarter. The position peaked at $44.8K in Q2 2025. 70 funds tracked by Wall St. Rank hold HURA as of Q3 2025.

  • Warberg Asset Management reported no remaining TuHURA Biosciences position as of Q3 2025 after selling out during the quarter.
  • Warberg Asset Management sold 20,000 TuHURA Biosciences shares in Q3 2025, an estimated $44.8K.
  • Warberg Asset Management first reported a position in TuHURA Biosciences in Q2 2025 and held it in 1 quarter.
  • Warberg Asset Management's TuHURA Biosciences position peaked at $44.8K in Q2 2025.
  • 70 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q3 2025.

Based on Warberg Asset Management's 13F filing for Q3 2025, filed 6 Nov 2025.